• 1
    Roberts LJ, Handman E, Foote SJ: Science, medicine and the future: Leishmaniasis. BMJ 2000; 321: 801804
  • 2
    Chung HL, Chow HK, Lu JP: The first two cases of transfusion kala-azar. Chin Med J 1948; 66: 325326
  • 3
    Andre R, Brumpt L, Dreyfus B, Passelecq A, Jacob S: Cutaneous leishmaniasis, cutaneous glandular leishmaniasis and transfusional kala-azar. Trop Dis Bull 1958; 55: 379381
  • 4
    Kostmann R, Barr M, Bengtsson E, Garnham PCC, Hult G: Kala-azar transferred by exchange blood transfusions in two Swedish infants. Proceedings of the Seventh International Congress of Tropical Medicine and Malaria. Brazil, Rio de Janeiro, 1963 September 1–11. 2: 384
  • 5
    Cohen C, Corazza F, De Mol P, Brasseur D: Leishmaniasis acquired in Belgium. Lancet 1991; 338: 128[Letter]
  • 6
    Mauny I, Blanchot I, Degeilh B, Dabadie A, Guiguen C, Roussey M: Viceral leishmaniasis in an infant in Brittany: discussion on the modes of transmission outside of the endemic zone. Pediatrie 1993; 48: 237239
  • 7
    Cummins D, Amin S, Halil O, Chiodini PL, Hewitt PE, Radley-Smith R: Viceral leishmaniasis after cardiac surgery. Arch Dis Child 1995; 72: 235236
  • 8
    Singh S, Chaudhry VP, Wali J: Transfusion-transmitted kala-azar in India. Transfusion 1996; 36: 848849
  • 9
    Mathur P, Samantaray JC: The first probable case of platelet-transfusion-transmitted visceral leishmaniasis. Transfus Med 2004; 14: 319321
  • 10
    Grogl M, Daugirda JL, Hoover DL, Magill AJ, Berman J: Survivability and infectivity of viscerotropic Leishmania tropica from Operation Desert Storm participants in human blood products maintained under blood bank conditions. Am J Trop Med Hyg 1993; 49: 308315
  • 11
    Paraguai de Sousa E, Esteves Pereira AP, Soares Machado FC, Melo MF, Souto-Padron T, Palatnik M, Palatnik-de-Sousa CB: Occurrence of Leishmania donovani parasitemia in plasma of infected hamsters. Acta Trop 2001; 80: 6975
  • 12
    Giger U, Oakley DA, Owens SD, Schantz P: Leishmania donovani transmission by packed RBC transfusion to anemic dogs in the United States. Transfusion 2002; 42: 381382
  • 13
    Owens SD, Oakley DA, Marryott K, Hatchett W, Walton R, Nolan TJ, Newton A, Steurer F, Schantz P, Giger U: Transmission of visceral leishmaniasis through blood transfusion from infected English foxhounds to anemic dogs. J Am Vet Med Assoc 2001; 219: 10761083
  • 14
    Palatnik-de-Sousa CB, Paraguai-de-Souza E, Gomes EM, Soares-Macha FC, Luz KG, Borojevic R: Transmission of visceral leishmaniasis by blood transfusion in hamsters. Braz J Med Biol Res 1996; 29: 13111315
  • 15
    le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, Rousseau D, Kubar J: Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999; 37: 19531957
  • 16
    Badaro RT, Jones TC, Carvalho JM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson W: New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154: 10031011
  • 17
    Pearson RD, de Queiroz Sousa A: Clinical spectrum of leishmaniasis. Clin Infect Dis 1995; 22: 113
  • 18
    Reiner SI, Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151177
  • 19
    Herwaldt BL: Leishmaniasis. Lancet 1999; 354: 11911199
  • 20
    Zempleni J, Galloway JR, McCormick DB: Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr 1996; 63: 5466
  • 21
    Unna K, Greslin J: Studies on the toxicity and pharmacology of riboflavin. J Pharmacol Exp Ther 2004; 75: 7580
  • 22
    Joshi PC: Ultraviolet radiation-induced photodegradation and 1O2, O2 production by riboflavin, lumichrome and lumiflavin. Indian J Biochem Biophys 1989; 26: 186189
  • 23
    Goodrich RP: The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang 2000; 78: 211215
  • 24
    Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP: Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877855
  • 25
    Perez-Pujol S, Tonda R, Lozano TM, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G: Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005; 45: 911919
  • 26
    AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP: Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45: 13351341
  • 27
    Li J, de Korte D, Woolum MD, Ruane PH, Keil SD, Lockerbie O, McLean R, Goodrich RP: Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products. Vox Sang 2004; 87: 8290
  • 28
    Li J, Lockerbie O, de Korte D, Rice J, McLean R, Goodrich RP: Evaluation of platelet mitochondria integrity after treatment with mirasol pathogen reduction technology. Transfusion 2005; 45: 920926
  • 29
    Kreutzer RD, Christensen HA: Characterization of leishmania spp. by isoenzyme electrophoresis. Am J Trop Med Hyg 1980; 29: 199208
  • 30
    Harms G, Schonian G, Feldmeier H: Leishmaniasis in Germany. Emerg Infect Dis 2003; 9: 872875
  • 31
    Morbidity and Mortality Weekly Report: Two cases of visceral leishmaniasis in U.S. military personnel – Afghanistan. MMWR 2004; 53: 265268
  • 32
    Morbidity and Mortality Weekly Report: Update: Cutaneous Leishmaniasis in U.S. Military Personnel – Southwest/Central Asia, 2002–2004. MMWR 2004; 53: 264265
  • 33
    Morbidity and Mortality Weekly Report: Viscerotropic Leishmaniasis in Persons Returning from Operation Desert Storm – 1990–1991. MMWR 1992; 41: 131134
  • 34
    AABB: AABB Association Bulletin #03:14. Bethesda, AABB, 2003
  • 35
    Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN: Visceral infection caused by leishmania tropica in veterans of operation desert storm. N Engl J Med 1993; 328: 13831387
  • 36
    Fleming AF: Opportunistic infections in AIDS in developed and developing countries. Trans R Soc Trop Med Hyg 1990; 84: 16
  • 37
    Medrano FJ, Hernandez-Quero J, Jimenez E, Pineda JA, Rivero A, Sanchez-Quijano A, Velez ID, Viciana P, Castillo R, Reyes MJ: Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS 1992; 6: 14991503